This partnership enables the use of over 1,700 IHC-validated antibodies from CST detected by fluorescent secondary antibodies for use on the COMET™, empowering researchers to develop antibody ...

In March 2022, AmoyDx received approval for the company’s PD-L1 Expression Detection Kit (IHC), which leverages the CST PD-L1 antibody validated for immunohistochemistry (IHC) and is used to ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services ... highly validated antibody products from initial discovery ...

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, today announced a comprehensive collaboration with Cell Signaling ...

"Our partnership with Bio-Rad in the past has enabled CST to combine our antibody expertise with Bio-Rad's strength in multiplexed assay technologies," said Christopher Bunker, CST's Director of ...

This partnership enables the use of over 1,700 IHC-validated antibodies from CST detected by fluorescent secondary antibodies for use on the COMET, empowering researchers to develop antibody ...